Statistics

Total Visits

Views
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 207

Total Visits per Month

August 2017 September 2017 October 2017 November 2017 December 2017 January 2018 February 2018
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 0 0 0 0 2 1 1

File Downloads

Views
ijo_34_4_1155_PDF published.pdf 108

Top Country Views

Views
United States 45
Canada 25
Germany 24
Sweden 22
China 18
France 11
United Kingdom 10
South Korea 6
Russia 6
India 2

Top City Views

Views
Nynäs 19
Miami Beach 17
Toronto 13
Beijing 8
Ottawa 6
Kansas City 5
Zhengzhou 5
Seoul 4
Dundas 3
Memphis 2